Related Experiment Video
Updated: Aug 5, 2025

A Unified Methodological Framework for Vestibular Schwannoma Research
Published on: June 20, 2017
Management of Neurofibromatosis Type 2-Associated Vestibular Schwannomas
Pawina Jiramongkolchai1, Marc S Schwartz2, Rick A Friedman3
1Division of Otolaryngology-Head and Neck Surgery, University of California San Diego School of Medicine, 200 West Arbor Drive, MC 8895, San Diego, CA 92103, USA.
Abstract:
Neurofibromatosis type 2 (NF2) is an autosomal dominant syndrome caused by a mutation in the NF2 suppressor gene and is characterized by the development of multiple benign tumors throughout the central nervous system. Bilateral vestibular schwannomas (VSs) are pathognomonic for NF2 and are associated with progressive hearing loss and eventual deafness in most patients. This review presents current management options for NF-2-associated VSs.
Related Concept Videos
Equilibrium and Balance
The Vestibular System
Esophageal Varices-II: Clinical Features and Management
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
Mitral Valve Prolapse III: Nursing Management
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
Mitral Stenosis III: Medical Management

